Recent mechanistic studies have revealed that the RNA aptamer Ep23 is a high-affinity molecular probe that targets EpCAM, demonstrating dual functionality in both selectively binding to EpCAM-expressing human carcinoma cells and facilitating efficient receptor-mediated endocytosis [151]. Here, EPCAM is linked to carcinoma.